Teva Pharmaceutical Industries (BSP:T1EV34) Dividend Yield %: 0.00% (As of Jun. 28, 2026)


BSP:T1EV34 Teva Pharmaceutical Industries Ltd BSP:T1EV34
59 GF Score
Price R$85.99
GF Value R$51.72
! 5 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries Dividend Yield %?

Teva Pharmaceutical Industries BSP:T1EV34 59 Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus rates BSP:T1EV34 with a GF Score™ of 59/100 and a GF Value™ of R$51.72. The stock has 5 warning signs investors should review. Among 517 Drug Manufacturers companies, Teva Pharmaceutical Industries ranks worse than 193423.4% on this metric.

As of today (2026-06-28), the Trailing Annual Dividend Yield of Teva Pharmaceutical Industries is 0.00%.

The historical rank and industry rank for Teva Pharmaceutical Industries's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Teva Pharmaceutical Industries was 7.92%. The lowest was 0.29%. And the median was 2.92%.

BSP:T1EV34's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.06
* Ranked among companies with meaningful Dividend Yield % only.

Teva Pharmaceutical Industries's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Teva Pharmaceutical Industries was 0.27. The lowest was 0.21. And the median was 0.24.

As of today (2026-06-28), the Forward Dividend Yield % of Teva Pharmaceutical Industries is 0.00%.

Teva Pharmaceutical Industries's Dividends per Share for the three months ended in Mar. 2026 was R$0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Teva Pharmaceutical Industries was 74.00% per year. The lowest was -14.10% per year. And the median was 22.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Teva Pharmaceutical Industries  (BSP:T1EV34) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Teva Pharmaceutical Industries Dividend Yield % Related Terms


Teva Pharmaceutical Industries Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Teva Pharmaceutical Industries's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries Dividend Yield % Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Teva Pharmaceutical Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSP:T1EV34 vs ZTS, UTHR, VTRS: Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Dividend Yield % falls into.


BSP:T1EV34
59GF Score
Teva Pharmaceutical Industries Ltd BSP:T1EV34
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teva Pharmaceutical Industries Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Teva Pharmaceutical Industries (BSP:T1EV34) has a Dividend Yield % of 0.00% as of Jun. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Teva Pharmaceutical Industries and its competitors. Over the past decade, Teva Pharmaceutical Industries' Dividend Yield % has ranged from 0.29 to 7.92. According to the industry distribution chart, Teva Pharmaceutical Industries ranks #999999 out of 517 companies in the Drug Manufacturers industry.
Is Teva Pharmaceutical Industries' Dividend Yield % too high?
Teva Pharmaceutical Industries' current Dividend Yield % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 7.92. Based on the distribution chart, Teva Pharmaceutical Industries ranks #999999 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Teva Pharmaceutical Industries has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Teva Pharmaceutical Industries' Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Teva Pharmaceutical Industries ranks #999999 out of 517 companies for Dividend Yield %. This places Teva Pharmaceutical Industries in the lower half of its industry. The industry median Dividend Yield % is 2.06. Historically, Teva Pharmaceutical Industries' own Dividend Yield % has ranged from 0.29 to 7.92 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.06, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Teva Pharmaceutical Industries and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teva Pharmaceutical Industries's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teva Pharmaceutical Industries stock overvalued right now?
Teva Pharmaceutical Industries (BSP:T1EV34) has a current Dividend Yield % of 0.00%. The stock's GF Value™ is R$51.72, compared to a current price of R$85.99 — trading 66.3% above its estimated fair value. The current Dividend Yield % is 0.00%. Teva Pharmaceutical Industries' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Teva Pharmaceutical Industries (BSP:T1EV34), the current Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teva Pharmaceutical Industries (BSP:T1EV34) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of R$85.99 is trading 66.3% above its estimated GF Value™ of R$51.72.

Key valuation signals for BSP:T1EV34:

  • Dividend Yield %: 0.00%
  • GF Value™: R$51.72 vs. price of R$85.99 (66.3% above fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the BSP:T1EV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
59GF Score

Get the complete analysis for BSP:T1EV34

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$85.99
Price
R$51.72
GF Value